Clinico-pathogenic similarities and differences between infection-related glomerulonephritis and C3 glomerulopathy

Y Wada, M Kamata, R Miyasaka, T Abe… - International Journal of …, 2023 - mdpi.com
Recently, the comprehensive concept of “infection-related glomerulonephritis (IRGN)” has
replaced that of postinfectious glomerulonephritis (PIGN) because of the diverse infection …

Treatment of C3 glomerulopathy in adult kidney transplant recipients: a systematic review

ML Gonzalez Suarez, C Thongprayoon, P Hansrivijit… - Medical …, 2020 - mdpi.com
Background: C3 glomerulopathy (C3G), a rare glomerular disease mediated by alternative
complement pathway dysregulation, is associated with a high rate of recurrence and graft …

[HTML][HTML] Alternative complement pathway inhibition with iptacopan for the treatment of C3 glomerulopathy-study design of the APPEAR-C3G trial

AS Bomback, D Kavanagh, M Vivarelli, M Meier… - Kidney International …, 2022 - Elsevier
Introduction Complement 3 glomerulopathy (C3G) is a rare kidney disease characterized by
dysregulation of the alternative pathway (AP) of the complement system. About 50% of …

[HTML][HTML] Efficacy and safety of iptacopan in patients with C3 glomerulopathy

E Wong, C Nester, T Cavero, A Karras… - Kidney international …, 2023 - Elsevier
Introduction Complement 3 glomerulopathy (C3G) is a rare inflammatory kidney disease
mediated by dysregulation of the alternative complement pathway. No targeted therapy …

[HTML][HTML] Clinical safety and efficacy of pegcetacoplan in a phase 2 study of patients with C3 glomerulopathy and other complement-mediated glomerular diseases

BP Dixon, LA Greenbaum, L Huang, S Rajan… - Kidney International …, 2023 - Elsevier
Introduction Dysregulated complement activation is likely the primary driver of disease in C3
glomerulopathy (C3G) and contributes to other complement-mediated diseases, including …

Longitudinal change in proteinuria and kidney outcomes in C3 glomerulopathy

F Caravaca-Fontán, M Díaz-Encarnación… - Nephrology Dialysis …, 2022 - academic.oup.com
Introduction The association between a change in proteinuria over time and its impact on
kidney prognosis has not been analysed in complement component 3 (C3) glomerulopathy …

[HTML][HTML] Clinicopathologic implications of complement genetic variants in kidney transplantation

Z Ren, SJ Perkins, L Love-Gregory, JP Atkinson… - Frontiers in …, 2021 - frontiersin.org
Genetic testing has uncovered rare variants in complement proteins associated with
thrombotic microangiopathy (TMA) and C3 glomerulopathy (C3G). Approximately 50% are …

Regulation of complement activation by heme oxygenase-1 (HO-1) in kidney injury

MG Detsika, EA Lianos - Antioxidants, 2021 - mdpi.com
Heme oxygenase is a cytoprotective enzyme with strong antioxidant and anti-apoptotic
properties. Its cytoprotective role is mainly attributed to its enzymatic activity, which involves …

C3 glomerulopathy associated with monoclonal gammopathy: impact of chronic histologic lesions and beneficial effects of clone-targeted therapies

F Caravaca-Fontán, L Lucientes, N Serra… - Nephrology Dialysis …, 2022 - academic.oup.com
Background C3 glomerulopathy associated with monoclonal gammopathy (C3G-MIg) is a
rare entity. Herein we analysed the clinical and histologic features of a cohort of C3G-MIg …

Deciphering the Genetic Code of Autoimmune Kidney Diseases

SUS Huang, O Kulatunge, KM O'Sullivan - Genes, 2023 - mdpi.com
Autoimmune kidney diseases occur due to the loss of tolerance to self-antigens, resulting in
inflammation and pathological damage to the kidneys. This review focuses on the known …